{"id":"W2528138059","doi":"10.1111/dom.12805","title":"Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: <scp>a</scp> systematic review and meta‐analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Boehringer Ingelheim; Amgen","keywords":"Dulaglutide; Exenatide; Medicine; Liraglutide; Internal medicine; Type 2 diabetes; Basal (medicine); Sitagliptin; Meta-analysis; Lixisenatide; Randomized controlled trial; Glucagon-like peptide 1 receptor; Diabetes mellitus; Endocrinology; Insulin; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0130871,0.002590409,0.0181564,0.004141708,0.0005454294,0.003257443,0.001861127,0.002202482,0.005701675],"category_scores_gemma":[0.02695136,0.00123131,0.03399984,0.005320441,0.0006609531,0.001512722,0.001239546,0.001721449,0.0003757532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003125003,"about_ca_system_score_gemma":0.003545964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006927653,"about_ca_topic_score_gemma":0.01368531,"domain_scores_codex":[0.990413,0.005209387,0.002345793,0.0007988938,0.0009875516,0.0002454479],"domain_scores_gemma":[0.9853814,0.01091553,0.002316768,0.0003529078,0.000825019,0.0002083593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002980652,0.00002459411,0.001497944,0.4419842,0.5442122,0.00007142284,0.00004937004,0.0003547984,0.000204997,0.0001063744,0.000663017,0.007850518],"study_design_scores_gemma":[0.001781592,0.0002820657,0.0021085,0.03326866,0.9605312,0.00006855367,0.00003222716,0.0001997566,0.000114608,0.0001526679,0.001441751,0.00001838566],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005687708,0.9911006,0.0005516991,0.0002985917,0.0002754089,0.0008041998,0.0007983943,0.00004484232,0.0004384808],"genre_scores_gemma":[0.2044815,0.7854224,0.002865243,0.001564435,0.0004456889,0.003225322,0.001252897,0.00005058904,0.0006917489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0181564,"threshold_uncertainty_score":0.06921202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03299279135512655,"score_gpt":0.2840780141662557,"score_spread":0.2510852228111292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}